No profile data available.
Kala Bio, Inc. (KALA) is a healthcare company in the eye treatment pharmaceuticals industry, based in Arlington, United States, with about 38 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was $0. Its market capitalization was $7.91 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.
$7.91 million as of December 4, 2025.
Listed companies of a similar size in the same industry (eye treatment pharmaceuticals) include Aldeyra Therapeutics, Inc. (ALDX), Hyperion DeFi, Inc. (HYPD), Kiora Pharmaceuticals, Inc. (KPRX).